4//SEC Filing
Linde Peter 4
Accession 0001209191-21-021553
CIK 0001679363other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 7:07 PM ET
Size
19.4 KB
Accession
0001209191-21-021553
Insider Transaction Report
Form 4
Linde Peter
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit (RSU)
2021-03-16−10,378→ 10,378 totalExp: 2021-09-16→ Common Stock (10,378 underlying) - Exercise/Conversion
Common Stock
2021-03-16+11,365→ 12,222 total - Exercise/Conversion
Common Stock
2021-03-16+10,378→ 22,600 total - Sale
Common Stock
2021-03-16$63.65/sh−9,558$608,398→ 13,042 total - Sale
Common Stock
2021-03-16$65.49/sh−381$24,951→ 11,100 total - Sale
Common Stock
2021-03-16$64.49/sh−1,561$100,662→ 11,481 total - Sale
Common Stock
2021-03-16$68.38/sh−500$34,190→ 10,600 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2021-03-16−11,365→ 34,095 totalExp: 2024-03-16→ Common Stock (11,365 underlying)
Footnotes (8)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F2]Includes 857 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 26, 2021.
- [F3]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.12 to $64.11 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.12 to $65.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.17 to $65.72 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The RSU vests 25% on each of March 16, 2021, March 16, 2022, March 16, 2023 and March 16, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F8]The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Morphic Holding, Inc.
CIK 0001679363
Entity typeother
Related Parties
1- filerCIK 0001805908
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 7:07 PM ET
- Size
- 19.4 KB